Jane Street
FLNA

Jane Street’s Filana Therapeutics FLNA Stock Holding History

Jane Street’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.7K Sell
21,100
-46,800
-69% -$96.3K ﹤0.01% 11073
2025
Q4 		$134K Buy
67,900
+57,600
+559% +$184K ﹤0.01% 10017
2025
Q3 		$30K Sell
10,300
-8,500
-45% -$19.5K ﹤0.01% 10459
2025
Q2 		$34K Sell
18,800
-209,200
-92% -$372K ﹤0.01% 9267
2025
Q1 		$342K Sell
228,000
-110,700
-33% -$279K ﹤0.01% 7583
2024
Q4 		$799K Sell
338,700
-203,800
-38% -$3.58M ﹤0.01% 5809
2024
Q3 		$16M Buy
542,500
+305,900
+129% +$7.04M ﹤0.01% 1434
2024
Q2 		$2.92M Sell
236,600
-26,700
-10% -$563K ﹤0.01% 3853
2024
Q1 		$5.34M Buy
263,300
+196,500
+294% +$4.53M ﹤0.01% 2526
2023
Q4 		$1.53M Sell
66,800
-106,900
-62% -$2.26M ﹤0.01% 4782
2023
Q3 		$2.89M Buy
173,700
+80,300
+86% +$1.59M ﹤0.01% 3433
2023
Q2 		$2.29M Buy
93,400
+48,300
+107% +$1.16M ﹤0.01% 3960
2023
Q1 		$1.09M Sell
45,100
-107,100
-70% -$2.97M ﹤0.01% 4840
2022
Q4 		$4.5M Sell
152,200
-130,400
-46% -$4.69M ﹤0.01% 2635
2022
Q3 		$11.8M Buy
282,600
+118,800
+73% +$3.21M 0.01% 1533
2022
Q2 		$4.61M Sell
163,800
-7,600
-4% -$192K ﹤0.01% 2794
2022
Q1 		$6.37M Sell
171,400
-127,700
-43% -$5.41M ﹤0.01% 2639
2021
Q4 		$13.1M Sell
299,100
-393,300
-57% -$20.6M ﹤0.01% 1584
2021
Q3 		$43M Buy
692,400
+434,200
+168% +$36.2M 0.02% 671
2021
Q2 		$22.1M Buy
258,200
+63,400
+33% +$3.4M 0.01% 1012
2021
Q1 		$8.76M Buy
194,800
+74,400
+62% +$2.93M ﹤0.01% 1690
2020
Q4 		$821K Sell
120,400
-6,900
-5% -$61.6K ﹤0.01% 4992
2020
Q3 		$1.47M Buy
+127,300
New +$574K ﹤0.01% 3495

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Jane Street's FLNA Position: Q1 2026 in Review

Jane Street reduced its Filana Therapeutics (FLNA) stake by 56% in Q1 2026, selling an estimated $593K and leaving 225,164 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #8670.

Jane Street first reported a position in FLNA in Q2 2013 and has held it in 31 quarters since. The position peaked at $14.9M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Jane Street held 225,164 shares of Filana Therapeutics worth $381K as of Q1 2026.
  • Jane Street sold 287,973 Filana Therapeutics shares in Q1 2026, an estimated $593K.
  • Filana Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8670 holding.
  • Jane Street first reported a position in Filana Therapeutics in Q2 2013 and has held it in 31 quarters since.
  • Jane Street's Filana Therapeutics position peaked at $14.9M in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.